Sagimet Biosciences

company

About

Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.

  • 11 - 50

Details

Last Funding Type
Series E
Last Funding Money Raised
$7M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Mar 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$7M
Sagimet Biosciences has raised a total of $7M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2019 from a Series E round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2019 Series E $7M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Sagimet Biosciences has made 1 investments. Their most recent investment was on Apr 3, 2020, when 98point6 raised $43M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 3, 2020 98point6
Series D $43M Health Care

Investors

Number of Lead Investors
Number of Investors
1
Sagimet Biosciences is funded by 1 investors. Qianhai Ark are the most recent investors.
Investor Name Lead Investor Funding Round
Qianhai Ark Series E